Heart rate vARiability and physical activity in inpatient treatMent of burnOut and DepressIon (HARMODI): protocol of a cross-sectional study with up to 8-week follow up

• Published in: BMJ open 2024-06, Vol.14 (6), p.e081299
• Main Authors: Turner, Wiebke, Brühl, Annette, Böker, Heinz, Schulze, Beate, Marschall, Katja, La Marca, Roberto, Pfaff, Michael, Russmann, Thomas, Schmidt-Trucksäss, Arno
• Format: Article
• Language: English
• Subjects: Adult; Autonomic Nervous System - physiopathology; Biomarkers; Burnout; Burnout, Psychological; Clinical trials; Cross-Sectional Studies; Depression & mood disorders; Depression - therapy; Exercise; Exercise Test; Female; Follow-Up Studies; Heart rate; Heart Rate - physiology; Humans; Inpatients - psychology; Male; Mental depression; Mental disorders; Mental health care; Middle Aged; Physical fitness; Physical fitness tests; PSYCHIATRY; Sports and Exercise Medicine; Stress
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2023-081299

IntroductionChronic stress can cause an imbalance within the autonomic nervous system, thereby affecting cardiovascular and mental health. Physical activity (PA) may have a positive effect on the autonomic nervous system and stress-related disorders, such as depression and burnout. Heart rate variability (HRV) is a non-invasive marker of the autonomic nervous system. However, limited and inconsistent data exist on the exact relationship between HRV, PA and depression and burnout symptoms. The HARMODI study aims to explore whether HRV is a feasible marker of depression and burnout symptoms and aims to evaluate the role of PA in the treatment of stress-related disorders.Methods and analysesThis is an observational study with a cross-sectional up to 8 week follow-up study design. A total of 153 patients, undergoing psychiatric inpatient treatment with burnout syndrome (Z73) and depressive episode (F32 or F33) or adjustment disorder (F43.2), will be recruited. Data on depression and burnout symptoms, HRV recordings (24-hour, supine, standing and exercise stress test), cognitive function, cardiorespiratory fitness, cardiovascular health, balance and strength will be collected at baseline (T1) and after up to 8 weeks (T2). Continuous data on PA and Ecological Momentary Assessments of exhaustion, mood and tension will be monitored daily throughout inpatient treatment. Multiple regression models, adjusted for potential confounders, will assess the association between HRV as the primary outcome, PA and depression and burnout severity score.Ethics and disseminationThe protocol has been approved by Swiss Ethics Committee, Cantonal Ethics Committee Zürich. Results of HARMODI will be disseminated through peer-reviewed journals and conference presentations.Trial registration number NCT05874856.